Sandu Pharmaceuticals Q4 Results
- BSE: 524703
- NSE: -
- ISIN: INE751D01014
- Sector: Biotechnology & Drugs
BSE
38.47
1.28 (3.44%)
1.28 (3.44%)Volume977.00
Updated: Fri 15 May, 2026 | 15:29:47
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Incomeâ‚ą16.85 Cr.(19.79%)
- Operating Profitâ‚ą0.41 Cr.(36.14%)
- Profit After Taxâ‚ą0.04 Cr.(-86.74%)
- Operating Margin2.42%(13.65%)
Note: Comparison is on YoY basis
Quarterly - Sandu Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 16.45 | 17.89 | -8.05% | 15.18 | 19.43% |
| Depreciation/ Amortization | 0.16 | 0.17 | -0.54% | 0.19 | 11.27% |
| Operating Income | 0.41 | 0.87 | -53.41% | 0.42 | 36.14% |
| Net Income | 0.04 | 0.98 | -95.56% | 0.59 | -86.74% |
| Other Operating Expenses Total | 7.01 | 7.19 | -2.41% | 6.32 | 39.83% |
| Net Income Before Taxes | 0.75 | 0.86 | -12.62% | 0.72 | 118.13% |
| Total Revenue | 16.85 | 18.76 | -10.17% | 15.60 | 19.79% |
| Selling/ General/ Admin Expenses Total | 2.74 | 2.65 | 3.64% | 2.47 | -2.99% |
| Diluted Normalized EPS | 0.04 | 1.01 | -96.04% | 0.61 | -88.03% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
âś•
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.